Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D Ho

Showing results (261-270 of 346) with videos related to

Pageof 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2002
Clinicopathologic correlations of genomic gains and losses in follicular lymphomaAndreas Viardot, Peter Möller, Josef Högel, et al.
Haematologica|March 12, 2010
Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantationKai Neben, Anna Jauch, Uta Bertsch, et al.
International Journal of Cancer|September 9, 2014
T cell-based targeted immunotherapies for patients with multiple myelomaLei Wang, Nan Jin, Anita Schmitt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studiesAssia L Angelova, Marc Aprahamian, Ginette Balboni, et al.
International Journal of Cancer|December 30, 2014
The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patientsVan T Hoang, Eike C Buss, Wenwen Wang, et al.
European Journal of Haematology|May 26, 2018
CD7 is expressed on a subset of normal CD34-positive myeloid precursorsKatharina Kriegsmann, Harald Löffler, Volker Eckstein, et al.
Cytometry. Part B, Clinical Cytometry|March 27, 2018
Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myelomaKatharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, et al.
Blood|February 29, 2008
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instabilityTilmann Bochtler, Ute Hegenbart, Friedrich W Cremer, et al.
Experimental Hematology|July 26, 2006
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristicsStefan Fruehauf, Timon Seeger, Patrick Maier, et al.
Transfusion|August 14, 2014
Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myelomaJian Cheng, Michael Schmitt, Patrick Wuchter, et al.
Pageof 35

Showing results (261-270 of 346) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2002
Clinicopathologic correlations of genomic gains and losses in follicular lymphomaAndreas Viardot, Peter Möller, Josef Högel, et al.
Haematologica|March 12, 2010
Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantationKai Neben, Anna Jauch, Uta Bertsch, et al.
International Journal of Cancer|September 9, 2014
T cell-based targeted immunotherapies for patients with multiple myelomaLei Wang, Nan Jin, Anita Schmitt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
Oncolytic rat parvovirus H-1PV, a candidate for the treatment of human lymphoma: In vitro and in vivo studiesAssia L Angelova, Marc Aprahamian, Ginette Balboni, et al.
International Journal of Cancer|December 30, 2014
The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patientsVan T Hoang, Eike C Buss, Wenwen Wang, et al.
European Journal of Haematology|May 26, 2018
CD7 is expressed on a subset of normal CD34-positive myeloid precursorsKatharina Kriegsmann, Harald Löffler, Volker Eckstein, et al.
Cytometry. Part B, Clinical Cytometry|March 27, 2018
Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myelomaKatharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, et al.
Blood|February 29, 2008
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instabilityTilmann Bochtler, Ute Hegenbart, Friedrich W Cremer, et al.
Experimental Hematology|July 26, 2006
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristicsStefan Fruehauf, Timon Seeger, Patrick Maier, et al.
Transfusion|August 14, 2014
Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myelomaJian Cheng, Michael Schmitt, Patrick Wuchter, et al.
Pageof 35